Human ehrlichiosis pathophysiology

Revision as of 18:03, 18 September 2017 by WikiBot (talk | contribs) (Changes made per Mahshid's request)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Human ehrlichiosis Microchapters

Home

Patient Information

Overview

Pathophysiology

Causes

Differentiating Human ehrlichiosis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Human ehrlichiosis pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Human ehrlichiosis pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Human ehrlichiosis pathophysiology

CDC on Human ehrlichiosis pathophysiology

Human ehrlichiosis pathophysiology in the news

Blogs on Human ehrlichiosis pathophysiology

Directions to Hospitals Treating Human ehrlichiosis

Risk calculators and risk factors for Human ehrlichiosis pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Pathophysiology

Ehrlichiae are small, gram-negative bacteria that primarily invade leukocytes (white blood cells), the same cells which fight disease by destroying microorganisms that enter the body. Ehrlichiae typically appear as minute, round bacteria (cocci), ranging from 1 to 3 µm (micrometers) in diameter. In the leukocytes, ehrlichiae divide to form vacuole-bound colonies known as morulae (plural for morula, which is the Latin word for mulberry, referring to the mulberry-like clustering of the dividing organisms). The formation of morulae is a defining characteristic of this group of bacterial pathogens (Figure A).

Taxonomy

The genus Ehrlichia is currently classified as a member of the tribe Ehrlichieae, of the family Rickettsiaceae, in the order Rickettsiales. The genus includes seven recognized species: E. canis, E. chaffeensis, E. equi, E. phagocytophila, E. risticii, E. ewingii, and E. sennetsu. A number of other named ehrlichiae, such as E. platys, E. bovis, E. ovina, and E. ondiri also cause disease in animals (Table 1). The names of the latter organisms are enclosed in quotation marks because they have not been formally proposed and accepted according to the rules of the International Code of Nomenclature of Bacteria, Bacteriological Code.

The ehrlichiae were initially grouped according to the type of blood cell most commonly infected (granulocyte, lymphocyte, monocyte, platelet), and disease classes have been termed "granulocytic (or granulocytotropic) ehrlichiosis" or "monocytic (or monocytotropic) ehrlichiosis." However, this type of classification may be misleading because some of the Ehrlichia species have been found in cells other than their chief target cell type. In addition, more than one species may be responsible for the broad category of "monocytic" or "granulocytic" ehrlichiosis (e.g., compare the HGE agent and E. ewingii in the figures below).

  • Figure B. Ehrlichia chaffeensis primarily infects mononuclear leukocytes (predominantly monocytes and macrophages), but may also be seen occasionally in the granulocytes of some patients with severe disease.
  • Figure C. The pathogen that causes human granulocytic ehrlichiosis (HGE) primarily infects granulocytes (neutrophils and rarely eosinophils). The pathogen is often referred to as the agent of HGE or the HGE agent. This species is very similar, or likely identical, to E. phagocytophila and E. equi.
  • Figure D. Ehrlichia ewingii primarily infects neutrophils and occasionally eosinophils and produces a disease clinically similar to HME and HGE. Most patients with this form of ehrlichiosis have also had other medical conditions causing immunosuppression (e.g., HIV infection, splenectomy, transplantation, immunosuppressive drugs).

Modern Classification

Using modern molecular biology techniques, we now know that Ehrlichia species form three distinct groups (see Figure 5 below). The species contained within these "genogroups" are also related to organisms not previously considered to be members of this genus. The classification of the genus Ehrlichia requires revision, and future studies may provide the additional data needed.

  • Figure D. Genetic relationship of Ehrlichia species and other bacteria based on similarity of 16rRNA gene
Figure D. Genetic relationship of Ehrlichia species and other bacteria based on similarity of 16rRNA gene
Figure D. Genetic relationship of Ehrlichia species and other bacteria based on similarity of 16rRNA gene


References

Template:WH Template:WS